Skip to main content
Clinical Trials/CTRI/2012/12/003189
CTRI/2012/12/003189
Completed
未知

Efficacy evaluation of Menâ??s Under Eye Serum on healthy human male volunteers.

ITC RD CENTRE0 sites35 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC RD CENTRE
Enrollment
35
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC RD CENTRE

Eligibility Criteria

Inclusion Criteria

  • 1\.Male subjects in generally good health.
  • 2\.Subjects in the age group of 25 to 65 years.
  • 3\.17\-18 subjects with moderate to severe under eye dark circles, 17\-18 Subjects with
  • puffiness, 17\-18 Subjects with moderate to severe fine lines and wrinkles in addition to
  • either of the above mentioned conditions.
  • 4\.Subjects free of any obvious infection of skin as determined by dermatologist.
  • 5\.Subject has not participated in a similar investigation in the past four weeks.
  • 6\.Subjects have not used a similar product for the last four weeks.
  • 7\.Subjects willing to give a written informed consent and come for regular follow up.

Exclusion Criteria

  • 1\.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc.
  • 2\.Currently or has been using a similar type of product within the last 1 month.
  • 3\.Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month.
  • 4\.Currently or has been involved in another skin care clinical investigation within the last 1 months.
  • 5\.Subjects who have pre\-existing or dormant dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator.
  • 6\.Subjects viewed by the investigator as not being able to complete the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials